The Medicines Company to Announce Third Quarter Financial Results on October 26, 2016

17 Oct 2016

The Medicines Company (NASDAQ:MDCO) has scheduled its quarterly conference call for October 26, 2016 at 8:30 a.m., Eastern Daylight Time, to discuss third-quarter financial results and operational developments.

The conference call will be available via phone and webcast. The dial-in information to access the call is:

U.S./Canada:     (877) 359-9508
International: (224) 357-2393
Conference ID: 98417278

A taped replay of the conference call will be available from 11:30 a.m., Eastern Daylight Time, following the conference call for one week. To hear a replay of the call, dial (855) 859-2056 (domestic) and (404) 537-3406 (international). Passcode for both dial-in numbers is 98417278.

This call is being webcast and can be accessed in the “Investors” section of The Medicines Company website. A replay of the webcast will also be available.

About The Medicines Company

The Medicines Company is a biopharmaceutical company driven by an overriding purpose—to save lives, alleviate suffering and contribute to the economics of healthcare. The Company’s mission is to create transformational solutions to address the most pressing healthcare needs facing patients, physicians and providers in three critical therapeutic areas: serious infectious disease care, cardiovascular care and surgery and perioperative care. The Company is headquartered in Parsippany, New Jersey, with global innovation centers in California and Switzerland.


Russo Partners
Matt Middleman, M.D., 212-845-4272
Investor Relations:
Krishna Gorti, MD, 973-290-6122
Vice President, Investor Relations

Contact Us

The Medicines Company
8 Sylvan Way
Parsippany, NJ 07054 USA
Tel 973 290 6000
Toll-free 800 388 1183
Global Medical Information